A novel, rapid and sensitive heterotypic cell adhesion assay for CD2-CD58 interaction, and its application for testing inhibitory peptides

被引:17
作者
Liu, JN
Vincent, TKC
Jois, SDS
机构
[1] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore
[2] Natl Univ Singapore, Dept Microbiol, Human Genome Lab, Singapore 117543, Singapore
关键词
CD2; CD58; Jurkat cells; Caco-2; cells; lymphocyte-epithelial adhesion assay; E-rosetting assay;
D O I
10.1016/j.jim.2004.04.026
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The immunoglobulin CD2 is a cell adhesion molecule that mediates T-cell activation by binding to its receptor CD58 on antigen-presenting cells (APCs). Modulation or inhibition of this interaction has been shown to be therapeutically useful. Erosetting assay is usually applied in the study of the modulation of CD2-CD58 interaction. In this study, we demonstrated a novel, rapid and sensitive heterotypic cell adhesion assay for CD2-CD58 interaction. The CD2 expression on the surface of Jurkat cells and the CD58 expression on the Caco-2 cells were confirmed by flow cytometry and ELISA studies, respectively. Then Jurkat cells were fluorescent-labeled with 2 muM of BCECF-AM for 45 min at 37 degreesC before adding to confluent Caco-2 monolayers cultured in 96-well culture dishes. After 30 min, non-adherent Jurkat cells were removed by washing with PBS, while the monolayer-associated Jurkat cells were lysed with 0.5 ml of 2% Triton X-100 in 0.1 M NaOH. Fluorescence (FL) was quantitated using a microplate fluorescence analyzer with BCECF's excitation maximum of 485 nm and emission maximum of 535 nm. This method was successfully applied for testing inhibitory peptides to CD2-CD58 interaction. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 49
页数:11
相关论文
共 40 条
[1]   LYMPHOID-CELLS IN INFECTIOUS-MONONUCLEOSIS CLASSIFIED ACCORDING TO T AND B CELL MARKERS [J].
AIUTI, F ;
ROCCHI, G ;
DAMELIO, R ;
GIUNTA, S ;
FIORILLI, M .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1975, 48 (03) :353-363
[2]   Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease [J].
Aruffo, A ;
Hollenbaugh, D .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (06) :683-686
[3]   THE CD58 (LFA-3) BINDING-SITE IS A LOCALIZED AND HIGHLY-CHARGED SURFACE-AREA ON THE AGFCC'C'' FACE OF THE HUMAN CD2 ADHESION DOMAIN [J].
ARULANANDAM, ARN ;
WITHKA, JM ;
WYSS, DF ;
WAGNER, G ;
KISTER, A ;
PALLAI, P ;
RECNY, MA ;
REINHERZ, EL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11613-11617
[4]   CD2 sets quantitative thresholds in T cell activation [J].
Bachmann, MF ;
Barner, M ;
Kopf, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1383-1391
[5]  
BLAND PW, 1986, IMMUNOLOGY, V58, P1
[6]   EXPRESSION AND MODULATION OF ADHESION MOLECULES ON HUMAN BRONCHIAL EPITHELIAL-CELLS [J].
BLOEMEN, PGM ;
VANDENTWEEL, MC ;
HENRICKS, PAJ ;
ENGELS, F ;
WAGENAAR, SS ;
RUTTEN, AAJJL ;
NIJKAMP, FP .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 9 (06) :586-593
[7]   Selective deletion of antigen-specific, activated T cells by a humanized mab to CD2 (medi-507) is mediated by NK cells [J].
Branco, L ;
Barren, P ;
Mao, SY ;
Pfarr, D ;
Kaplan, R ;
Postema, C ;
Langerman, S ;
Koenig, S ;
Johnson, S .
TRANSPLANTATION, 1999, 68 (10) :1588-1596
[8]  
CUNNINGHAM AC, 1995, IMMUNOLOGY, V86, P279
[9]   CD2 and the nature of protein interactions mediating cell-cell recognition [J].
Davis, SJ ;
Ikemizu, S ;
Wild, MK ;
van der Merwe, PA .
IMMUNOLOGICAL REVIEWS, 1998, 163 :217-236
[10]   ANCHORING MECHANISMS FOR LFA-3 CELL-ADHESION GLYCOPROTEIN AT MEMBRANE-SURFACE [J].
DUSTIN, ML ;
SELVARAJ, P ;
MATTALIANO, RJ ;
SPRINGER, TA .
NATURE, 1987, 329 (6142) :846-848